Unknown

Dataset Information

0

High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.


ABSTRACT:

Background

Mucin13 (MUC13) is a transmembrane glycoprotein that is aberrantly expressed in ovarian and gastro-intestinal tumors, but its role in renal cell carcinoma remains elusive. The purpose of this study is to evaluate the prognostic value of MUC13 expression in patients with non-metastatic clear cell renal cell carcinoma (ccRCC) after surgical resection.

Results

MUC13 high expression was associated with high Fuhrman grade (p < 0.001), high SSIGN score (p = 0.011), early recurrence (p < 0.001) and poor survival (p < 0.001). Multivariate Cox regression analysis identified MUC13 expression as an independent prognostic factor for RFS and OS of ccRCC patients. A nomogram integrating MUC13 expression and other independent prognosticators was established to predict RFS and OS of ccRCC patients. Optimal agreement was shown between the predictions and observations in calibration curves.

Materials and methods

This study enrolled 410 postoperative non-metastatic ccRCC patients at a single institution. Clinicopathologic variables, recurrence-free survival (RFS), and overall survival (OS) were recorded. MUC13 expression was detected by immunohistochemical staining in tumor specimens. Association of MUC13 expression with clinicopathological factors was explored. Kaplan-Meier analysis was performed to compare survival curves. Univariate and multivariate Cox regression models were used to analyze the impact of prognostic factors on RFS and OS. A prognostic nomogram was constructed based on the independent prognostic factors identified by multivariate analysis.

Conclusions

MUC13 high expression is a novel independent adverse prognostic factor of clinical outcome in non-metastatic ccRCC patients after surgery.

SUBMITTER: Xu Z 

PROVIDER: S-EPMC5352342 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.

Xu Zhiying Z   Liu Yidong Y   Yang Yuanfeng Y   Wang Jieti J   Zhang Guodong G   Liu Zheng Z   Fu Hangcheng H   Wang Zewei Z   Liu Haiou H   Xu Jiejie J  

Oncotarget 20170101 5


<h4>Background</h4>Mucin13 (MUC13) is a transmembrane glycoprotein that is aberrantly expressed in ovarian and gastro-intestinal tumors, but its role in renal cell carcinoma remains elusive. The purpose of this study is to evaluate the prognostic value of MUC13 expression in patients with non-metastatic clear cell renal cell carcinoma (ccRCC) after surgical resection.<h4>Results</h4>MUC13 high expression was associated with high Fuhrman grade (p < 0.001), high SSIGN score (p = 0.011), early recu  ...[more]

Similar Datasets

| S-EPMC5325393 | biostudies-literature
| S-EPMC5546472 | biostudies-other
| S-EPMC5021026 | biostudies-literature
| S-EPMC6332661 | biostudies-literature
| S-EPMC5421958 | biostudies-literature
| S-EPMC5173110 | biostudies-literature
| S-EPMC5078046 | biostudies-literature
| S-EPMC5356697 | biostudies-other
2017-08-17 | GSE88948 | GEO
| S-EPMC5013447 | biostudies-literature